Acute coronary syndrome in a 17-year-old female with systemic lupus erythematosus

被引：0

作者：

Meyringer R. ^{[1
,4
]}

Oberhoffer R. ^{[2
]}

Holmer S. ^{[3
]}

Schölmerich J. ^{[1
]}

Müller-Ladner U. ^{[1
]}

机构：

[1] Klinik und Poliklinik für Innere Medizin I, Universität Regensburg

[2] Kinderklinik und Poliklinik, Technische Universität München

[3] Klinik und Poliklinik für Innere Medizin II, Universität Regensburg

[4] Medizinische Klinik, Juliusspital, 97070 Würzburg

来源：

Medizinische Klinik | 2005年 / 100卷 / 5期

关键词：

Hyperlipidemia; Myocardial infarction; Systemic lupus erythematosus;

D O I：

10.1007/s00063-005-1035-7

中图分类号：

学科分类号：

摘要：

□ Case Report: A 17-year-old female was admitted to the hospital with epigastric pain radiating into the chest and neck. The patient had a known, long-standing history of systemic lupus erythematosus (SLE) with predominantly renal involvement. Diagnostic examinations including left heart catheterization showed acute myocardial infarction based on a coronary three-vessel disease. Percutaneous transluminal coronary angioplasty (PTCA) with dilatation of the left marginal branch and the left posterolateral branch was performed. 8 weeks after PTCA, the patient was admitted again showing occlusion of the same coronary artery. A coronary stent was implanted which, after 8 weeks, also showed signs of occlusion. □ This case report describes premature myocardial infarction in a young woman with SLE and addresses and discusses the problem that myocardial infarction in SLE can be caused by atherosclerosis and/or arteritis of the coronary arteries. © Urban & Vogel.

引用

页码：279 / 283

页数：4

共 13 条

[1]

Adu D., Cross J., Jayne D.R., Treatment of systemic lupus erythematosus with mycophenolate mofetil, Lupus, 10, pp. 203-208, (2001)

[2]

Fearon W.F., Cooke J.P., Acute myocardial infarction in a young woman with systemic lupus erythematosus, Vasc Med, 1, pp. 19-23, (1996)

[3]

Homcy C.J., Liberthson R.R., Fallon J.T., Et al., Ischemic heart disease in systemic lupus erythematosus in the young patient: Report of six cases, Am J Cardiol, 49, pp. 478-484, (1982)

[4]

Karrar A., Sequeira W., Block J.A., Coronary artery disease in systemic lupus erythematosus: A review of the literature, Semin Arthritis Rheum, 30, pp. 436-513, (2001)

[5]

Leong K.H., Koh E.T., Feng P.H., Et al., Lipid profiles in patients with systemic lupus erythematosus, J Rheumatol, 21, pp. 1264-1267, (1994)

[6]

Manzi S., Meilahn E.N., Rairie J.E., Et al., Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study, Am J Epidemiol, 145, pp. 408-415, (1997)

[7]

Miller D.J., Maisch S.A., Perez M.D., Et al., Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome, J Rheumatol, 22, pp. 768-773, (1995)

[8]

Petri M., Roubenoff R., Dallal G.E., Et al., Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus, Lancet, 348, pp. 1120-1124, (1996)

[9]

Steinberg D., Lewis A., Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis, Circulation, 95, pp. 1062-1071, (1997)

[10]

Vaarala O., Antiphospholipid antibodies and myocardial infarction, Lupus, 7, 2 SUPPL., (1998)

← 1 2 →